RZLT · Rezolute Inc. Common Stock (NV)
View on chartInsiders & Stakes
| HANDOK, INC. | ▲ Buy | Open Market | 5,942,617 Shares held | 7/22/2022 | View profile |
| Nevan C. Elam Director | ▼ Sell | Tax Withholding | 605,497 Shares held | 7/2/2026 | View profile |
| Daron Evans CFO | ▼ Sell | Tax Withholding | 411,400 Shares held | 7/2/2026 | View profile |
| Brian Kenneth Roberts Sr VP, Clinic Development | ▼ Sell | Tax Withholding | 293,851 Shares held | 7/2/2026 | View profile |
| Young-Jin Kim | ▲ Buy | Grant | 170,950 Shares held | 11/19/2025 | View profile |
| Wladimir Hogenhuis Director | ▲ Buy | Open Market | 119,675 Shares held | 12/16/2025 | View profile |
| Sunil Ratilal Karnawat Chief Commercial Officer | ▼ Sell | Tax Withholding | 69,275 Shares held | 9/2/2026 | View profile |
| Nerissa Kreher Director | ▲ Buy | Grant | 58,576 Shares held | 11/19/2025 | View profile |
| Philippe Fauchet | ▲ Buy | Grant | 55,500 Shares held | 11/19/2025 | View profile |
| Gil M. Labrucherie Director | ▲ Buy | Grant | 55,500 Shares held | 11/19/2025 | View profile |
| Erik Harris Director | ▲ Buy | Grant | 21,000 Shares held | 11/19/2025 | View profile |
Transaction History
| Sunil Ratilal Karnawat | ▼ Sell | Tax Withholding | 2,267 | $10K | 9/2/2026 |
| Brian Kenneth Roberts | ▼ Sell | Tax Withholding | 3,062 | $15K | 7/2/2026 |
| Nevan C. Elam | ▼ Sell | Tax Withholding | 8,004 | $40K | 7/2/2026 |
| Daron Evans | ▼ Sell | Tax Withholding | 3,062 | $15K | 7/2/2026 |
| Daron Evans | ▲ Buy | Open Market | 10,000 | $29K | 3/30/2026 |
| Brian Kenneth Roberts | ▼ Sell | Tax Withholding | 11,439 | $34K | 3/2/2026 |
| Daron Evans | ▼ Sell | Tax Withholding | 11,438 | $34K | 3/2/2026 |
| Nevan C. Elam | ▼ Sell | Tax Withholding | 27,618 | $83K | 3/2/2026 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 28,000 | $48K | 12/16/2025 |
| Wladimir Hogenhuis | ▲ Buy | Open Market | 5,650 | $10K | 12/16/2025 |
| Daron Evans | ▲ Buy | Open Market | 40,000 | $71K | 12/15/2025 |
| Daron Evans | ▲ Buy | Open Market | 2,500 | $4K | 12/15/2025 |
| Daron Evans | ▲ Buy | Open Market | 2,500 | $4K | 12/15/2025 |
| Nevan C. Elam | ▲ Buy | Open Market | 32,000 | $51K | 12/15/2025 |
| Sunil Ratilal Karnawat | ▲ Buy | Open Market | 12,000 | $19K | 12/15/2025 |
| Sunil Ratilal Karnawat | ▲ Buy | Open Market | 100 | $160 | 12/15/2025 |
| Daron Evans | ▲ Buy | Open Market | 10,549 | $53K | 12/9/2025 |
| Nevan C. Elam | ▲ Buy | Grant | 317,000 | $0 | 11/19/2025 |
| Daron Evans | ▲ Buy | Grant | 107,000 | $0 | 11/19/2025 |
| Nerissa Kreher | ▲ Buy | Grant | 21,000 | $0 | 11/19/2025 |
| Brian Kenneth Roberts | ▲ Buy | Grant | 123,000 | $0 | 11/19/2025 |
| Sunil Ratilal Karnawat | ▲ Buy | Grant | 32,000 | $0 | 11/19/2025 |
| Wladimir Hogenhuis | ▲ Buy | Grant | 21,000 | $0 | 11/19/2025 |
| Erik Harris | ▲ Buy | Grant | 21,000 | $0 | 11/19/2025 |
| Young-Jin Kim | ▲ Buy | Grant | 21,000 | $0 | 11/19/2025 |
| Philippe Fauchet | ▲ Buy | Grant | 21,000 | $0 | 11/19/2025 |
| Gil M. Labrucherie | ▲ Buy | Grant | 21,000 | $0 | 11/19/2025 |
| Sunil Ratilal Karnawat | ▲ Buy | Grant | 25,000 | $0 | 8/18/2025 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 2,500 | $11K | 6/25/2025 |
| Daron Evans | ▲ Buy | Open Market | 5,000 | $20K | 6/24/2025 |
| Young-Jin Kim | ▲ Buy | Open Market | 1,230,769 | $4.0M | 6/13/2025 |
| Nerissa Kreher | ▲ Buy | Open Market | 3,076 | $10K | 6/13/2025 |
| Nevan C. Elam | ▲ Buy | Grant | 68,000 | $0 | 6/10/2025 |
| Nerissa Kreher | ▲ Buy | Grant | 9,000 | $0 | 6/10/2025 |
| Gil M. Labrucherie | ▲ Buy | Grant | 9,000 | $0 | 6/10/2025 |
| Wladimir Hogenhuis | ▲ Buy | Grant | 9,000 | $0 | 6/10/2025 |
| Young-Jin Kim | ▲ Buy | Grant | 9,000 | $0 | 6/10/2025 |
| Daron Evans | ▲ Buy | Grant | 26,000 | $0 | 6/10/2025 |
| Philippe Fauchet | ▲ Buy | Grant | 9,000 | $0 | 6/10/2025 |
| Brian Kenneth Roberts | ▲ Buy | Grant | 26,000 | $0 | 6/10/2025 |
| Wladimir Hogenhuis | ▲ Buy | Open Market | 6,758 | $20K | 3/31/2025 |
| Nevan C. Elam | ▲ Buy | Open Market | 12,302 | $35K | 3/27/2025 |
| Daron Evans | ▲ Buy | Open Market | 10,000 | $29K | 3/26/2025 |
| Daron Evans | ▲ Buy | Open Market | 10,000 | $29K | 3/26/2025 |
| Wladimir Hogenhuis | ▲ Buy | Open Market | 10,000 | $47K | 2/18/2025 |
| Brian Kenneth Roberts | ▲ Buy | Grant | 77,000 | $0 | 2/16/2025 |
| Daron Evans | ▲ Buy | Grant | 77,000 | $0 | 2/16/2025 |
| Nerissa Kreher | ▲ Buy | Grant | 25,500 | $0 | 2/16/2025 |
| Young-Jin Kim | ▲ Buy | Grant | 25,500 | $0 | 2/16/2025 |
| Gil M. Labrucherie | ▲ Buy | Grant | 25,500 | $0 | 2/16/2025 |
| Nevan C. Elam | ▲ Buy | Grant | 204,000 | $0 | 2/16/2025 |
| Wladimir Hogenhuis | ▲ Buy | Grant | 25,500 | $0 | 2/16/2025 |
| Philippe Fauchet | ▲ Buy | Grant | 25,500 | $0 | 2/16/2025 |
| Daron Evans | ▲ Buy | Open Market | 10,000 | $43K | 12/18/2024 |
| Daron Evans | ▲ Buy | Open Market | 9,000 | $41K | 12/12/2024 |
| Wladimir Hogenhuis | ▲ Buy | Open Market | 4,259 | $20K | 9/24/2024 |
| Wladimir Hogenhuis | ▲ Buy | Open Market | 4,815 | $20K | 6/25/2024 |
| Young-Jin Kim | ▲ Buy | Open Market | 1,250,000 | $5.0M | 6/25/2024 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 3,000 | $12K | 6/14/2024 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 4,000 | $16K | 6/14/2024 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 300 | $1K | 6/14/2024 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 300 | $1K | 6/14/2024 |
| Daron Evans | ▲ Buy | Open Market | 40,000 | $162K | 6/14/2024 |
| Daron Evans | ▲ Buy | Open Market | 451 | $2K | 5/29/2024 |
| Daron Evans | ▲ Buy | Open Market | 2,942 | $10K | 5/24/2024 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 1,500 | $4K | 5/23/2024 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 6,000 | $16K | 5/23/2024 |
| Daron Evans | ▲ Buy | Open Market | 58 | $165 | 5/23/2024 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 500 | $1K | 3/28/2024 |
| Daron Evans | ▲ Buy | Open Market | 20,000 | $34K | 3/15/2024 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 10,000 | $19K | 3/14/2024 |
| Daron Evans | ▲ Buy | Open Market | 50,000 | $96K | 3/8/2024 |
| Young-Jin Kim | ▲ Buy | Open Market | 36,503 | $70K | 3/7/2024 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 500 | $925 | 3/7/2024 |
| Nevan C. Elam | ▲ Buy | Open Market | 5,000 | $8K | 2/26/2024 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 2,000 | $3K | 2/26/2024 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 6,000 | $10K | 2/23/2024 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 7,000 | $9K | 2/16/2024 |
| Daron Evans | ▲ Buy | Open Market | 4,500 | $6K | 2/16/2024 |
| Daron Evans | ▲ Buy | Open Market | 4,500 | $6K | 2/16/2024 |
| Daron Evans | ▲ Buy | Open Market | 41,900 | $54K | 2/16/2024 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 5,000 | $9K | 7/3/2023 |
| HANDOK, INC. | ▲ Buy | Open Market | 3,157,895 | $12.0M | 7/22/2022 |
| Young-Jin Kim | ▲ Buy | Open Market | 78,947 | $300K | 7/22/2022 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 300 | $884 | 5/19/2022 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 200 | $572 | 5/18/2022 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 1,000 | $3K | 5/17/2022 |
| Gil M. Labrucherie | ▲ Buy | Open Market | 52,631 | $200K | 5/4/2022 |
| Wladimir Hogenhuis | ▲ Buy | Open Market | 25,000 | $95K | 5/4/2022 |
| Brian Kenneth Roberts | ▲ Buy | Open Market | 21,052 | $80K | 5/4/2022 |
| HANDOK, INC. | ▲ Buy | Open Market | 769,231 | $5.0M | 10/15/2021 |
| Wladimir Hogenhuis | ▲ Buy | Open Market | 7,693 | $50K | 10/15/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Rezolute Q4 EPS Misses Estimates, Reports Fiscal 2026 Results
Rezolute reported fourth-quarter and full-year fiscal 2026 financial results, with an EPS of $(0.20) missing the expected $(0.15). The company also provided a business update alongside these figures. The stock is currently trading near its support level, reflecting the market's reaction to the earnings miss.
Rezolute Q4 EPS Misses Estimates, Reports Fiscal 2026 Results. Rezolute reported fourth-quarter and full-year fiscal 2026 financial results, with an EPS of $(0.20) missing the expected $(0.15). The company also provided a business update alongside these figures. The stock is currently trading near its support level, reflecting the market's reaction to the earnings miss.